Kraj: Stany Zjednoczone
Język: angielski
Źródło: NLM (National Library of Medicine)
PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5)
Cosmetic Dermatology Research Institute, LLC.
TOPICAL
OTC DRUG
OTC monograph final
PYRITHIONE ZINC- PYRITHIONE ZINC SHAMPOO COSMETIC DERMATOLOGY RESEARCH INSTITUTE, LLC. _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may_ _be marketed if they comply with applicable regulations and policies. FDA has not_ _evaluated whether this product complies._ ---------- 71440-001-08 PYRITHIONE ZINC pyrithione zinc shampoo PRODUCT INFORMATION PRODUCT TYPE HUMAN OTC DRUG ITEM CODE (SOURCE) NDC:71440-001 ROUTE OF ADMINISTRATION TOPICAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRENGTH PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ 5) PYRITHIONE ZINC 2.41 g in 237 mL INACTIVE INGREDIENTS INGREDIENT NAME STRENGTH PANTHENOL (UNII: WV9CM0O67Z) FD&C BLUE NO. 1 (UNII: H3R47K3TBD) FD&C YELLOW NO. 5 (UNII: I753WB2F1M) HEXYLENE GLYCOL (UNII: KEH0A3F75J) D&C VIOLET NO. 2 (UNII: 350KA7O6HK) WATER (UNII: 059QF0KO0R) SODIUM HYDROXIDE (UNII: 55X04QC32I) POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) (UNII: 0L414VCS5Y) LINALOOL, (+)- (UNII: F4VNO44C09) CAPRYLYL GLYCOL (UNII: 00YIU5438U) SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U) COCAMIDE (UNII: 3YXD33R71G) PHENOXYETHANOL (UNII: HIE492ZZ3T) PRODUCT CHARACTERISTICS COLOR blue SCORE SHAPE SIZE FLAVOR IMPRINT CODE CONTAINS PACKAGING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:71440-001- 08 237 mL in 1 BOTTLE; Type 0: Not a Combination Product 08/27/2021 MARKETING INFORMATION MARKETING CATEGORY APPLICATION NUMBER OR MONOGRAPH CITATION MARKETING START DATE MARKETING END DATE OTC monograph final part358H 03/07/2016 LABELER - Cosmetic Dermatology Research Institute, LLC. (833043586) REGISTRANT - Chemco Corporation. (032495954) ESTABLISHMENT NAME ADDRESS ID/FEI BUSINESS OPERATIONS Chemco Corporation 032495954 manufacture(71440-001) Cosmetic Dermatology Research Institute, LLC. Revised: 5/2022 Przeczytaj cały dokument